UK DERMATOLOGY CLINICAL TRIALS NETWORK (UK DCTN)

Registered charity 1115745 · accounts filings on the Charity Commission register

The main purpose of the UKDCTN is to conduct independent, high quality, multi-centre clinical trials to answer questions of importance to clinicians and patients in dermatology. The Network is open to trial suggestions from anyone with an interest in skin disease. The Network provides 'hands on' advice and guidance in developing clinical trials. All UKDCTN trials are non-commercial.

Causes: The Advancement Of Health Or Saving Of Lives · website · Get email alerts

Latest income
£26k
Latest spending
£20k
Registered
2006
Accounts read
FY2026

Financial health, per its FY2026 accounts

The accounts have been examined by an independent examiner who confirmed that no material matters came to their attention suggesting non-compliance with accounting records or the accounts themselves. The examiner stated there were no other matters requiring attention for a proper understanding of the accounts. The document does not provide specific financial figures regarding reserves, income, or expenditure.

Automated summary of the FY2026 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Accounts independently examined (not a full audit). Discloses 3 of 6 completeness components.

Trustees · trustee networks

Trustee list from the Charity Commission register (current, not historical).

Operates in: Ireland · Scotland · Throughout England And Wales

Income and spending

Financial year endIncomeSpending
31/03/2026£26k£20k
31/03/2025£20k£26k
31/03/2024£24k£21k
31/03/2023£24k£19k
31/03/2022£23k£26k

Common questions

Is UK DERMATOLOGY CLINICAL TRIALS NETWORK (UK DCTN) financially healthy?

Per its FY2026 accounts: The accounts have been examined by an independent examiner who confirmed that no material matters came to their attention suggesting non-compliance with accounting records or the accounts themselves. The examiner stated there were no other matters requiring attention for a proper understanding of the accounts. The document does not provide specific financial figures regarding reserves, income, or expenditure. Its FY2026 accounts were independently examined.